Deposition of bismuth by Yersinia enterocolitica
- PMID: 1522824
- DOI: 10.1007/BF00202054
Deposition of bismuth by Yersinia enterocolitica
Abstract
Yersinia enterocolitica 8081c cultures in exponential growth were incubated for 1 h in 0.1% microcrystalline bismuth subsalicylate (BSS) suspensions. Scanning electron microscopy (SEM) revealed microcrystals directly bound to BSS-treated bacteria. Energy dispersive spectroscopy (EDS) X-ray microanalysis of the attached microcrystals confirmed that the crystals were the microcrystalline BSS. X-ray spectra positive for bismuth were also obtained by SEM-EDS X-ray microanalysis of whole bacteria, suggesting metal incorporation into the bacteria in regions absent of bound microcrystals. Transmission electron microscopy of thin sections of embedded preparations of BSS-treated exponential-growth-phase bacteria showed electron-dense deposits in the periphery of the bacteria. Y. enterocolitica cultures that were in stationary phase at the time of incubation with microcrystalline BSS showed no evidence of the electron-dense deposits and EDS spectra were negative for bismuth. Bacteria incubated in the absence of microcrystalline BSS also lacked electron-dense deposits. Scanning transmission electron microscopy used in conjunction with EDS X-ray microanalysis to view and analyze semi-thick sections (250-300 nm) of embedded preparations of BSS-treated bacteria in exponential growth confirmed that the electron-dense deposits at the periphery of the bacteria are the sites of bismuth depositions.
Similar articles
-
Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.Med Microbiol Immunol. 1992;181(3):131-43. doi: 10.1007/BF00202053. Med Microbiol Immunol. 1992. PMID: 1522823
-
In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S11-5. doi: 10.1093/clinids/12.supplement_1.s11. Rev Infect Dis. 1990. PMID: 2406851
-
Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.Gut Microbes. 2015;6(2):93-100. doi: 10.1080/19490976.2015.1008336. Gut Microbes. 2015. PMID: 25901890 Free PMC article.
-
Bismuth subsalicylate: history, chemistry, and safety.Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S3-8. doi: 10.1093/clinids/12.supplement_1.s3. Rev Infect Dis. 1990. PMID: 2406853 Review.
-
Bismuth subsalicylate in the treatment and prevention of diarrheal disease.Drug Intell Clin Pharm. 1987 Sep;21(9):687-93. doi: 10.1177/106002808702100901. Drug Intell Clin Pharm. 1987. PMID: 3308391 Review.
Cited by
-
Microbial genomics and the periodic table.Appl Environ Microbiol. 2004 Feb;70(2):647-55. doi: 10.1128/AEM.70.2.647-655.2004. Appl Environ Microbiol. 2004. PMID: 14766537 Free PMC article. Review. No abstract available.
-
Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.Med Microbiol Immunol. 1992;181(3):131-43. doi: 10.1007/BF00202053. Med Microbiol Immunol. 1992. PMID: 1522823
-
Antimicrobial activities of synthetic bismuth compounds against Clostridium difficile.Antimicrob Agents Chemother. 1999 Mar;43(3):582-8. doi: 10.1128/AAC.43.3.582. Antimicrob Agents Chemother. 1999. PMID: 10049270 Free PMC article.
-
Metabolism of bismuth subsalicylate and intracellular accumulation of bismuth by Fusarium sp. strain BI.Appl Environ Microbiol. 2005 Feb;71(2):876-82. doi: 10.1128/AEM.71.2.876-882.2005. Appl Environ Microbiol. 2005. PMID: 15691943 Free PMC article.
-
Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea.Dig Dis Sci. 2021 Jul;66(7):2323-2335. doi: 10.1007/s10620-020-06509-7. Epub 2020 Aug 8. Dig Dis Sci. 2021. PMID: 32772204 Free PMC article.